Source link : https://www.newshealth.biz/health-news/glp-1-drugs-in-masld-tied-to-lower-risk-of-cirrhosis-death/
GLP-1 receptor agonist use was associated with a reduced risk of progressing to cirrhosis and related complications in patients with diabetes and metabolic dysfunction-associated steatotic liver disease (MASLD), according to an analysis of Veterans Affairs data. In a matched cohort study of more than 30,000 patients, use of a GLP-1 agonist was associated with a […]
Author : News Health
Publish date : 2024-09-16 17:43:45
Copyright for syndicated content belongs to the linked Source.